Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

School-based hepatitis B vaccination programme and adolescent multiple sclerosis.

A D Sadovnick, D W Scheifele

    Lancet (London, England)
    |February 22, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.

    Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
    Same author

    Canadian vaccine research networks: Vaccine safety resources for Canada.

    Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
    Same author

    Multiple sclerosis in men: management considerations.

    Journal of neurology·2016
    Same author

    Birth outcomes of pregnancies fathered by men with multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2014
    Same author

    Colony stimulation factor 1 receptor (CSF1R) is not a common cause of multiple sclerosis.

    European journal of neurology·2013
    Same author

    Reproductive decision making after the diagnosis of multiple sclerosis (MS).

    Multiple sclerosis (Houndmills, Basingstoke, England)·2012
    Same journal

    Inherited retinal degenerations: clinical phenotypes and emerging therapies.

    Lancet (London, England)·2026
    Same journal

    Documenting hospice care.

    Lancet (London, England)·2026
    Same journal

    After the wood chipper.

    Lancet (London, England)·2026
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    See all related articles

    Hepatitis B vaccination did not show any link to multiple sclerosis in British Columbia adolescents. This study found no evidence connecting the hepatitis B vaccine program to multiple sclerosis or other demyelinating diseases.

    Area of Science:

    • Neurology
    • Immunology
    • Public Health

    Background:

    • Investigated the potential association between hepatitis B vaccination and the incidence of multiple sclerosis (MS) in adolescents.
    • Examined epidemiological data from British Columbia before and after the implementation of a hepatitis B vaccination program.

    Discussion:

    • Analyzed temporal trends in MS diagnoses in relation to vaccination rollout.
    • Considered potential confounding factors and biases in the study design.

    Key Insights:

    • No statistically significant increase in multiple sclerosis or other demyelinating diseases was observed following the introduction of the hepatitis B vaccination program.
    • The findings do not support a causal relationship between hepatitis B vaccination and MS in the adolescent population studied.

    Related Experiment Videos

    Outlook:

    • Further research may explore long-term effects or specific subpopulations.
    • Reinforces the safety profile of the hepatitis B vaccine regarding neurological conditions.